LOGO
LOGO

NRx Pharma To Report Suicidal Bipolar Depression Trial Results This Month

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
rttnewslogo20mar2024

It is estimated that every 27 seconds, someone in the U.S. attempts suicide. The risk of Acute Suicidal Ideation and Behavior, or ASIB, is uniquely high in patients during bipolar depressive episodes, compared to those with major depressive disorder, thought disorders, and personality disorders. Between 11% to 20% of individuals diagnosed with bipolar disorder will ultimately succumb to suicide, according to reports.

The stock we are bringing to your attention today is that of NRx Pharmaceuticals Inc. (NRXP), which is developing a drug for suicidal treatment-resistant bipolar depression.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update: April 13 – April 17, 2026

April 17, 2026 15:29 ET
The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.